简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
اردو
Errante Review: Profit Cancellations and Regulatory Warnings Pile Up
Abstract:A wave of user complaints accuses Errante of cancelling profitable trades and blocking withdrawals. Regulatory warnings from Japan's FSA and Indonesia's BAPPEBTI appear on the broker's WikiFX profile alongside a score of 6.91.

Errante, founded in 2019 in Seychelles, offers forex and CFD trading under CySEC and offshore Seychelles FSA licences. Yet a growing pattern of user complaints and regulatory disclosures now demands scrutiny from anyone considering this broker.
Complaint Pattern: Profits Cancelled, Withdrawals Blocked
A consistent thread runs through complaints on WikiFX: profitable trades are cancelled or reversed while losing trades stand. A Vietnamese trader reported in March 2026 that the broker allegedly recovers client profits whenever trades turn profitable, claiming rule violations while “relying on a licence from a reputable global financial authority” to appear legitimate.

Screenshot submitted by the user with the complaint (2026-03)
A US-based VIP account holder filed in February 2026 that Errante manipulated a stop-loss on a EURUSD position, triggering a 40-pip stop-out. According to the complaint, support attributed it to slippage.

Screenshot submitted by the user with the complaint (2026-02)
Other grievances reinforce the pattern. A Japanese user reported that Errante froze their account and revoked profits citing shared IP addresses, a claim the user called baseless. A Hong Kong trader described shifting crypto-network excuses each time a withdrawal was attempted. These complaints span multiple countries and time periods, pointing to a systemic issue.
Regulatory Red Flags
Errante holds a CySEC licence in Cyprus (383/20, under Notely Trading Ltd) and an offshore Seychelles FSA licence (SD038). The Seychelles entity , most frequently named in complaints , operates under offshore regulation, which generally offers weaker client protections.
Two regulatory disclosures on WikiFX amplify concern. Japan's FSA issued a warning in August 2025 regarding an entity conducting unregistered financial instruments business from a location “identical or strikingly similar” to several warned entities, a disclosure that appears on Errante's regulatory profile. Indonesia's BAPPEBTI included Errante among domains blocked during a 2022 crackdown on illegal commodity futures trading websites.
Basic Information
Errante offers four account tiers: Standard ($50 minimum), Premium ($1,000), VIP ($5,000), and Tailor Made ($15,000), with leverage up to 1:1000. Instruments include forex, indices, commodities, metals, shares, and cryptocurrencies. Deposit methods cover wire transfers, cards, e-wallets, and crypto. The broker lists offices in Cyprus, Malaysia, Nigeria, Seychelles, and Uruguay.
WikiFX Score: What 6.91 Means
Errante scores 6.91 on WikiFX, below the threshold for an unreservedly favourable rating. While the CySEC licence contributes credibility on paper, the volume of complaints concentrated on profit cancellation and withdrawal obstruction weighs against it. The score captures this tension: regulatory registration exists, but user experiences tell a different story.
Final Thoughts
The overlap between user complaints , cancelled profits, blocked withdrawals, arbitrary rule enforcement , and regulatory attention from two jurisdictions makes Errante a broker that demands caution. The pattern spans multiple regions and account types, suggesting the risk is structural rather than incidental.
Traders considering Errante should verify current CySEC and FSA licence statuses independently, deposit only what they can afford to lose, and test withdrawals with a small amount before committing larger funds. Use the WikiFX App to track real-time ratings, newly filed complaints, and regulatory updates , a quick check before trading can avert costly surprises.
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.










